Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations

计划入组 104 人 · 首次发布于 2020 年 7 月 27 日

Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer

计划入组 59 人 · 首次发布于 2017 年 3 月 22 日

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

计划入组 50 人 · 首次发布于 2023 年 8 月 9 日

MAP2K4 inhibitors (cancer)

MAP2K4 inhibitors (Astex Pharmaceuticals)

MAP4K4 inhibitors (Genentech)

Amivantamab Shows Promise in Colorectal Cancer as Phase 3 Trials Launch Following Encouraging Phase 1b/2 Results

BREAKWATER Study Reveals ctDNA Clearance Predicts Survival in BRAF V600E-Mutant Colorectal Cancer

PAS-004 Shows Favorable Safety and Early Efficacy in MAPK-Driven Solid Tumors